GLOW 70MG | Skin Rejuvenation & Repair Blend

The GLOW blend combines BPC-157, TB-500 and GHK-Cu for studies of skin and connective-tissue repair. BPC-157 contributes VEGF-driven angiogenesis and gut/tendon repair activity, TB-500 contributes actin regulation, cell migration and scar modulation, and GHK-Cu contributes copper-dependent collagen and glycosaminoglycan synthesis. The rationale is sequential: angiogenesis supports nutrient delivery, cell migration populates the repair site, and copper-peptide signalling drives matrix remodelling. Direct studies of the three-peptide blend are limited, so researchers include single-agent controls and interpret results against the individual literature on BPC-157 (Sikiric et al., Current Pharmaceutical Design, 2011), thymosin beta-4 (Goldstein et al., Trends in Molecular Medicine, 2005) and GHK-Cu (Pickart, Journal of Biomaterials Science, Polymer Edition, 2008).

The preparation is used to model dermal remodelling, wound closure, skin ageing, scar formation and recovery, and to test whether the combination improves outcomes compared with each peptide alone. The blend supplies 70mg of total peptide content in a single 3ml research-grade vial. Store the lyophilized blend at -20C, protect it from light, and reconstitute with bacteriostatic water according to institutional protocols. Common research questions concern the optimal ratio of the three peptides, the stability of GHK-Cu in the presence of the other peptides, and how blend outcomes compare with sequential single-agent treatment.

This product is intended strictly for laboratory research by qualified professionals. It is not approved for human consumption, clinical treatment or therapeutic use. A 70mg vial typically contains 50mg GHK-Cu, 10mg BPC-157 and 10mg TB-500, so the copper peptide dominates by mass. Reconstitute gently, because GHK-Cu foams and TB-500 is sensitive to shear. Skin-focused endpoints include collagen density, elastin fibre organisation, transepidermal water loss and wrinkle scoring, while wound models add closure rate and histology. Include single-peptide arms to determine whether the copper peptide or the repair peptides drive the observed effect.